The blood levels of Fintepla (fenfluramine) are mostly within the lower range among treated children and adults with…
Articles by Marta Figueiredo, PhD
Treatment with low-dose aripiprazole — a newer class of antipsychotic medication — in combination with psychotherapy, and behavioral and occupational…
Olivetolic acid, a precursor of cannabidiol (CBD), resulted in protective effects against fever-induced seizures in a mouse model of…
Nearly one month of repeated dosing of BMB-101, Bright Minds Biosciences’ experimental oral therapy for Dravet syndrome, was…
Stoke Therapeutics’ investigational therapy STK-001 is generally safe and results in a trend toward a reduction in seizure frequency…
People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of…
A no-cost genetic screening program, sponsored by Stoke Therapeutics, helped speed up molecular diagnosis of SCN1A-related diseases, including Dravet…
The first wave of COVID-19Â in Europe severely disrupted access to care and raised stress and anxiety in people with…
The investigational oral therapy Soticlestat (OV935/TAK-935), developed by Ovid Therapeutics and Takeda Pharmaceuticals, safely and effectively lowers…
Epilepsy surgery may be ineffective, and even detrimental, in people with Dravet syndrome caused by mutations in the…